Prevention of endemic healthcare-associated Clostridium difficile infection: reviewing the evidence (Q37770405)

22 August 2017

1 reference

title

Prevention of endemic healthcare-associated Clostridium difficile infection: reviewing the evidence (English)

1 reference

22 August 2017

Clostridium difficile

0 references

author name string

J Hsu

1

1 reference

22 August 2017

C Abad

2

1 reference

22 August 2017

M Dinh

3

1 reference

22 August 2017

Nasia Safdar

4

1 reference

22 August 2017

language of work or name

English

0 references

publication date

6 July 2010

1 reference

The American Journal of Gastroenterology

22 August 2017

1 reference

22 August 2017

105

1 reference

22 August 2017

2327-39; quiz 2340

1 reference

22 August 2017

11

1 reference

Clostridium difficile colitis

22 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Clostridium difficile--Associated diarrhea: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

National point prevalence of Clostridium difficile in US health care facility inpatients, 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Recommendations for surveillance of Clostridium difficile-associated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Clostridium difficile colonization and diarrhea at a tertiary care hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Increasing hospitalization and death possibly due to Clostridium difficile diarrheal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Estimated incidence of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

An epidemic, toxin gene-variant strain of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Narrative review: the new epidemic of Clostridium difficile-associated enteric disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Peripartum Clostridium difficile infection: case series and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

An audit of the use of manual handling equipment and their microbiological flora--implications for infection control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Nosocomial acquisition of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Measures to control and prevent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Clostridium difficile in long-term-care facilities for the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Infection control measures to limit the spread of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Treatment of Clostridium difficile-associated disease: old therapies and new strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Emergence of Clostridium difficile-associated disease in North America and Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

The role of handwashing in prevention of endemic intensive care unit infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Elimination of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit after hand washing with triclosan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Can we beat MRSA now we know its genome sequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

The use of antiseptics for handwashing by medical personnel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Handwashing--the Semmelweis lesson forgotten?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Compliance with handwashing in a teaching hospital. Infection Control Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Arguments for alcoholic hand disinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Lack of association between the increased incidence of Clostridium difficile-associated disease and the increasing use of alcohol-based hand rubs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Marketing hand hygiene in hospitals--a case study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Reduction in nosocomial transmission of drug-resistant bacteria after introduction of an alcohol-based handrub

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Avoiding problems: evidence-based selection of medical gloves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Association of contaminated gloves with transmission of Acinetobacter calcoaceticus var. anitratus in an intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Safety of patients isolated for infection control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

A randomized crossover study of disposable thermometers for prevention of Clostridium difficile and other nosocomial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Isolation of Clostridium difficile from patients and the environment of hospital wards

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Activity of a dry mist hydrogen peroxide system against environmental Clostridium difficile contamination in elderly care wards.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Occupational asthma and rhinitis due to glutaraldehyde: changes in nasal lavage fluid after specific inhalatory challenge test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Risk factors for Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Risk factors for Clostridium difficile toxin-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Epidemic Clostridium difficile-associated diarrhea: role of second- and third-generation cephalosporins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Clostridium difficile-associated diarrhoea in patients with community-acquired lower respiratory infection being treated with levofloxacin compared with beta-lactam-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Fluoroquinolone use and Clostridium difficile-associated diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Quinolone use as a risk factor for nosocomial Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five-year period in a district general hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Antibiotic prescribing policy and Clostridium difficile diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Clostridium difficile-associated diarrhea: epidemiological data from Western Australia associated with a modified antibiotic policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Favorable Impact of a Multidisciplinary Antibiotic Management Program Conducted During 7 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

A prospective study of Clostridium difficile infection and colonization in pediatric oncology patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

The prevalence and nosocomial acquisition of Clostridium difficile in elderly hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Clostridium difficile-associated diarrhea in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Recurrent Clostridium difficile diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Probiotics in human infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Probiotic spectra of lactic acid bacteria (LAB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Lactobacillus bacteremia and endocarditis: review of 45 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Safety of probiotics that contain lactobacilli or bifidobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Saccharomyces cerevisiae fungemia: an adverse effect of Saccharomyces boulardii probiotic administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Saccharomyces cerevisiae fungemia: an emerging infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.254

21 January 2018

Identifiers

DOI

10.1038/AJG.2010.254

1 reference

22 August 2017

1 reference